Literature DB >> 26063860

Reducing Unnecessary and Duplicate Ordering for Ovum and Parasite Examinations and Clostridium difficile PCR in Immunocompromised Patients by Using an Alert at the Time of Request in the Order Management System.

Caitlin C Otto1, Susan L Shuptar1, Philippe Milord2, Connor J Essick3, Reshma Nevrekar4, Svetlana L Granovsky5, Susan K Seo6, N Esther Babady1, Steven C Martin6, Yi-Wei Tang7, Melissa S Pessin3.   

Abstract

We implemented hospital information system (HIS) alerts to deter unnecessary test orders for ovum and parasite (O&P) exams and Clostridium difficile PCR. The HIS alerts decreased noncompliant O&P orders (orders after >72 h of hospitalization) from 49.8% to 30.9%, an overall decrease of 19%, and reduced noncompliant C. difficile PCR orders (orders <7 days after a previous positive result) from 30.6% to 19.2%, an overall decrease of 31.9%.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26063860      PMCID: PMC4508420          DOI: 10.1128/JCM.00968-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Clinical decision support systems could be modified to reduce 'alert fatigue' while still minimizing the risk of litigation.

Authors:  Aaron S Kesselheim; Kathrin Cresswell; Shobha Phansalkar; David W Bates; Aziz Sheikh
Journal:  Health Aff (Millwood)       Date:  2011-12       Impact factor: 6.301

2.  Unnecessary repeat Clostridium difficile PCR testing in hospitalized adults with C. difficile-negative diarrhea.

Authors:  J A Nistico; J E Hage; P E Schoch; B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-15       Impact factor: 3.267

3.  Recommendations for surveillance of Clostridium difficile-associated disease.

Authors:  L Clifford McDonald; Bruno Coignard; Erik Dubberke; Xiaoyan Song; Teresa Horan; Preeta K Kutty
Journal:  Infect Control Hosp Epidemiol       Date:  2007-01-25       Impact factor: 3.254

4.  Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Authors:  Stuart H Cohen; Dale N Gerding; Stuart Johnson; Ciaran P Kelly; Vivian G Loo; L Clifford McDonald; Jacques Pepin; Mark H Wilcox
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

5.  Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.

Authors:  N Esther Babady; Jeffrey Stiles; Phyllis Ruggiero; Perminder Khosa; David Huang; Susan Shuptar; Mini Kamboj; Timothy E Kiehn
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

Review 6.  Antidiarrheal agents for the management of treatment-related diarrhea in cancer patients.

Authors:  C Ippoliti
Journal:  Am J Health Syst Pharm       Date:  1998-08-01       Impact factor: 2.637

7.  Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay.

Authors:  Elisabeth Aichinger; Cathy D Schleck; William S Harmsen; Lisa M Nyre; Robin Patel
Journal:  J Clin Microbiol       Date:  2008-09-10       Impact factor: 5.948

8.  Alerting physicians during electronic order entry effectively reduces unnecessary repeat PCR testing for Clostridium difficile.

Authors:  Robert F Luo; Suzanne Spradley; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

9.  Work-up for infectious diarrhea after allogeneic hematopoietic stem cell transplantation: single specimen testing results in cost savings without compromising diagnostic yield.

Authors:  M Kamboj; C N Mihu; K Sepkowitz; N A Kernan; G A Papanicolaou
Journal:  Transpl Infect Dis       Date:  2007-05-19       Impact factor: 2.228

10.  A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a).

Authors:  Ellen Jo Baron; J Michael Miller; Melvin P Weinstein; Sandra S Richter; Peter H Gilligan; Richard B Thomson; Paul Bourbeau; Karen C Carroll; Sue C Kehl; W Michael Dunne; Barbara Robinson-Dunn; Joseph D Schwartzman; Kimberle C Chapin; James W Snyder; Betty A Forbes; Robin Patel; Jon E Rosenblatt; Bobbi S Pritt
Journal:  Clin Infect Dis       Date:  2013-07-10       Impact factor: 9.079

View more
  3 in total

1.  Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.

Authors:  Cynthia Y Truong; Saurabh Gombar; Richard Wilson; Gopalakrishnan Sundararajan; Natasa Tekic; Marisa Holubar; John Shepard; Alexandra Madison; Lucy Tompkins; Neil Shah; Stan Deresinski; Lee F Schroeder; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2017-03-01       Impact factor: 5.948

2.  Fecal calprotectin concentrations in cancer patients with Clostridium difficile infection.

Authors:  Taojun He; Samuel E Kaplan; Luz A Gomez; Xuedong Lu; Lakshmi V Ramanathan; Mini Kamboj; Yi-Wei Tang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-21       Impact factor: 3.267

3.  The Role of Diagnostic Stewardship in Clostridioides difficile Testing: Challenges and Opportunities.

Authors:  Frances J Boly; Kimberly A Reske; Jennie H Kwon
Journal:  Curr Infect Dis Rep       Date:  2020-02-17       Impact factor: 3.725

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.